Latest Articles
Activin A is a functional component of the anti-endometriotic drug Endoferin.
Endometriosis is a prevalent gynecological condition affecting up to 25-40% of women with infertility. Endoferin, a protein complex derived from the bovine ovarian follicles, has demonstrated high efficacy in clinical …
Published: July 31, 2026, midnight
Lotus Endometriosis Institute Releases Guide On Missed Diagnosis Amid Care Gaps - usatoday.com
Lotus Endometriosis Institute Releases Guide On Missed Diagnosis Amid Care Gaps usatoday.com
Published: July 30, 2026, 11:49 p.m.
Lotus Endometriosis Institute Releases Guide On Missed Diagnosis Amid Care Gaps - USA Today
Lotus Endometriosis Institute Releases Guide On Missed Diagnosis Amid Care Gaps USA Today
Published: July 30, 2026, 11:49 p.m.
Following backlash, this lifesaving endometriosis and breast cancer drug will be free indefinitely - bodyandsoul.com.au
Following backlash, this lifesaving endometriosis and breast cancer drug will be free indefinitely bodyandsoul.com.au
Published: July 30, 2026, 11:45 p.m.
Karyopharm plummets as Xpovio fails in phase 3 trial for endometrial cancer - Seeking Alpha
Karyopharm plummets as Xpovio fails in phase 3 trial for endometrial cancer Seeking Alpha
Published: July 30, 2026, 11:38 p.m.
Karyopharm slumps after Xpovio misses mark in Phase III endometrial cancer study - FirstWord Pharma
Karyopharm slumps after Xpovio misses mark in Phase III endometrial cancer study FirstWord Pharma
Published: July 30, 2026, 9:59 p.m.
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint - TipRanks
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint TipRanks
Published: July 30, 2026, 9:16 p.m.
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint - tipranks.com
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint tipranks.com
Published: July 30, 2026, 9:16 p.m.
Karyopharm endometrial cancer trial misses primary endpoint By Investing.com - Investing.com Nigeria
Karyopharm endometrial cancer trial misses primary endpoint By Investing.com Investing.com Nigeria
Published: July 30, 2026, 8:42 p.m.
Karyopharm endometrial cancer trial misses primary endpoint - Investing.com
Karyopharm endometrial cancer trial misses primary endpoint Investing.com
Published: July 30, 2026, 8:31 p.m.
Link copied to clipboard!